0:00
24:51
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)

Altri episodi di "AAAAI Podcast: Conversations from the World of Allergy"